

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | negative regulation of cell killing (GO:0031342) | 5.27011268 |
| 2 | negative regulation of leukocyte mediated cytotoxicity (GO:0001911) | 5.27011268 |
| 3 | antigen processing and presentation of endogenous peptide antigen via MHC class I (GO:0019885) | 4.95814171 |
| 4 | antigen processing and presentation of endogenous peptide antigen (GO:0002483) | 4.95814171 |
| 5 | antigen processing and presentation of exogenous peptide antigen via MHC class I, TAP-independent (G | 4.69571751 |
| 6 | antigen processing and presentation of endogenous antigen (GO:0019883) | 4.34921312 |
| 7 | detection of other organism (GO:0098543) | 4.29401727 |
| 8 | detection of bacterium (GO:0016045) | 4.08064542 |
| 9 | positive regulation by symbiont of host defense response (GO:0052509) | 4.05988747 |
| 10 | modulation by symbiont of host defense response (GO:0052031) | 4.05988747 |
| 11 | modulation by organism of immune response of other organism involved in symbiotic interaction (GO:00 | 4.05988747 |
| 12 | modulation by organism of defense response of other organism involved in symbiotic interaction (GO:0 | 4.05988747 |
| 13 | positive regulation by organism of defense response of other organism involved in symbiotic interact | 4.05988747 |
| 14 | modulation by symbiont of host immune response (GO:0052553) | 4.05988747 |
| 15 | regulation of interferon-beta biosynthetic process (GO:0045357) | 3.79250631 |
| 16 | detection of external biotic stimulus (GO:0098581) | 3.76923363 |
| 17 | positive regulation of interferon-alpha production (GO:0032727) | 3.74968997 |
| 18 | positive regulation of interleukin-2 biosynthetic process (GO:0045086) | 3.68374936 |
| 19 | positive regulation of nitric-oxide synthase biosynthetic process (GO:0051770) | 3.65818186 |
| 20 | positive regulation of gamma-delta T cell activation (GO:0046645) | 3.65117002 |
| 21 | regulation of interferon-alpha production (GO:0032647) | 3.54391789 |
| 22 | negative regulation of T cell mediated immunity (GO:0002710) | 3.48469312 |
| 23 | negative regulation of lymphocyte mediated immunity (GO:0002707) | 3.48075512 |
| 24 | regulation of dendritic cell antigen processing and presentation (GO:0002604) | 3.43943444 |
| 25 | T cell migration (GO:0072678) | 3.42948007 |
| 26 | leukocyte aggregation (GO:0070486) | 3.41680116 |
| 27 | response to peptidoglycan (GO:0032494) | 3.41413696 |
| 28 | neutrophil activation involved in immune response (GO:0002283) | 3.39377146 |
| 29 | germinal center formation (GO:0002467) | 3.39371526 |
| 30 | negative thymic T cell selection (GO:0045060) | 3.38597923 |
| 31 | B cell receptor signaling pathway (GO:0050853) | 3.38211602 |
| 32 | positive regulation of B cell differentiation (GO:0045579) | 3.37977317 |
| 33 | detection of biotic stimulus (GO:0009595) | 3.33130418 |
| 34 | response to interleukin-15 (GO:0070672) | 3.31101134 |
| 35 | negative T cell selection (GO:0043383) | 3.30789588 |
| 36 | immunoglobulin mediated immune response (GO:0016064) | 3.29669690 |
| 37 | regulation of mast cell degranulation (GO:0043304) | 3.28325862 |
| 38 | macrophage activation (GO:0042116) | 3.24678162 |
| 39 | negative regulation of leukocyte mediated immunity (GO:0002704) | 3.16886333 |
| 40 | regulation of antigen processing and presentation (GO:0002577) | 3.16563207 |
| 41 | regulation of T cell tolerance induction (GO:0002664) | 3.16540647 |
| 42 | regulation of B cell receptor signaling pathway (GO:0050855) | 3.14910907 |
| 43 | macrophage activation involved in immune response (GO:0002281) | 3.14567800 |
| 44 | positive regulation of interleukin-8 biosynthetic process (GO:0045416) | 3.09646884 |
| 45 | complement activation, alternative pathway (GO:0006957) | 3.09497683 |
| 46 | positive regulation of mast cell activation (GO:0033005) | 3.08746661 |
| 47 | cellular response to interleukin-15 (GO:0071350) | 3.07692014 |
| 48 | regulation of alpha-beta T cell proliferation (GO:0046640) | 3.07529717 |
| 49 | response to muramyl dipeptide (GO:0032495) | 3.06502246 |
| 50 | regulation of tolerance induction (GO:0002643) | 3.06260699 |
| 51 | regulation of T cell mediated cytotoxicity (GO:0001914) | 3.06136670 |
| 52 | respiratory burst (GO:0045730) | 3.04463206 |
| 53 | positive thymic T cell selection (GO:0045059) | 3.03489314 |
| 54 | tolerance induction (GO:0002507) | 3.03068803 |
| 55 | regulation of mast cell activation (GO:0033003) | 3.02611305 |
| 56 | regulation of antigen processing and presentation of peptide antigen (GO:0002583) | 3.01241655 |
| 57 | regulation of mast cell activation involved in immune response (GO:0033006) | 3.00105868 |
| 58 | T-helper 1 type immune response (GO:0042088) | 2.97665698 |
| 59 | * response to type I interferon (GO:0034340) | 2.97282174 |
| 60 | regulation of tumor necrosis factor biosynthetic process (GO:0042534) | 2.96322635 |
| 61 | * cellular response to type I interferon (GO:0071357) | 2.95405033 |
| 62 | * type I interferon signaling pathway (GO:0060337) | 2.95405033 |
| 63 | positive regulation of T cell mediated cytotoxicity (GO:0001916) | 2.92978169 |
| 64 | response to interferon-beta (GO:0035456) | 2.92473592 |
| 65 | negative regulation of interleukin-12 production (GO:0032695) | 2.89065836 |
| 66 | positive regulation of CD4-positive, alpha-beta T cell differentiation (GO:0043372) | 2.86838045 |
| 67 | NIK/NF-kappaB signaling (GO:0038061) | 2.86065315 |
| 68 | antigen processing and presentation via MHC class Ib (GO:0002475) | 2.86015705 |
| 69 | regulation of interleukin-12 production (GO:0032655) | 2.85890160 |
| 70 | positive regulation of antigen receptor-mediated signaling pathway (GO:0050857) | 2.85466427 |
| 71 | regulation of myeloid leukocyte mediated immunity (GO:0002886) | 2.85027018 |
| 72 | positive regulation of interleukin-17 production (GO:0032740) | 2.84719260 |
| 73 | positive regulation of type 2 immune response (GO:0002830) | 2.84417848 |
| 74 | defense response to protozoan (GO:0042832) | 2.83594103 |
| 75 | disruption of cells of other organism involved in symbiotic interaction (GO:0051818) | 2.83348794 |
| 76 | killing of cells in other organism involved in symbiotic interaction (GO:0051883) | 2.83348794 |
| 77 | negative regulation of cytokine production involved in immune response (GO:0002719) | 2.81702338 |
| 78 | positive regulation of tumor necrosis factor biosynthetic process (GO:0042535) | 2.81668293 |
| 79 | T cell selection (GO:0045058) | 2.81637577 |
| 80 | positive regulation of type I interferon-mediated signaling pathway (GO:0060340) | 2.81392050 |
| 81 | triglyceride-rich lipoprotein particle remodeling (GO:0034370) | 2.79160563 |
| 82 | regulation of leukocyte degranulation (GO:0043300) | 2.78154770 |
| 83 | regulation of T-helper 1 cell differentiation (GO:0045625) | 2.77774859 |
| 84 | positive regulation of heterotypic cell-cell adhesion (GO:0034116) | 2.77435370 |
| 85 | Arp2/3 complex-mediated actin nucleation (GO:0034314) | 2.77191405 |
| 86 | lipopolysaccharide-mediated signaling pathway (GO:0031663) | 2.77026214 |
| 87 | myeloid dendritic cell differentiation (GO:0043011) | 2.77007372 |
| 88 | leukocyte degranulation (GO:0043299) | 2.76860736 |
| 89 | detection of molecule of bacterial origin (GO:0032490) | 2.76447102 |
| 90 | peptidyl-glutamic acid carboxylation (GO:0017187) | 2.75958514 |
| 91 | protein carboxylation (GO:0018214) | 2.75958514 |
| 92 | response to immune response of other organism involved in symbiotic interaction (GO:0052564) | 2.73841224 |
| 93 | response to host immune response (GO:0052572) | 2.73841224 |
| 94 | regulation of B cell differentiation (GO:0045577) | 2.73638027 |
| 95 | regulation of interleukin-12 biosynthetic process (GO:0045075) | 2.70264361 |
| 96 | response to protozoan (GO:0001562) | 2.69366246 |
| 97 | fatty acid beta-oxidation using acyl-CoA oxidase (GO:0033540) | 2.65374455 |
| 98 | pinocytosis (GO:0006907) | 2.65262264 |
| 99 | regulation of protein activation cascade (GO:2000257) | 2.64627726 |
| 100 | * response to interferon-alpha (GO:0035455) | 2.64070368 |
| 101 | negative regulation of phagocytosis (GO:0050765) | 2.63474881 |
| 102 | alpha-linolenic acid metabolic process (GO:0036109) | 2.62374332 |
| 103 | regulation of gamma-delta T cell differentiation (GO:0045586) | 2.61121450 |
| 104 | reactive oxygen species biosynthetic process (GO:1903409) | 2.59569410 |
| 105 | positive regulation of interferon-beta production (GO:0032728) | 2.58007110 |
| 106 | regulation of complement activation (GO:0030449) | 2.57568988 |
| 107 | negative regulation of granulocyte differentiation (GO:0030853) | 2.57374672 |
| 108 | B cell mediated immunity (GO:0019724) | 2.56573290 |
| 109 | modulation of growth of symbiont involved in interaction with host (GO:0044144) | 2.56381895 |
| 110 | regulation of growth of symbiont in host (GO:0044126) | 2.56381895 |
| 111 | negative regulation of growth of symbiont in host (GO:0044130) | 2.56381895 |
| 112 | negative regulation of growth of symbiont involved in interaction with host (GO:0044146) | 2.56381895 |
| 113 | cellular extravasation (GO:0045123) | 2.55263731 |
| 114 | regulation of gamma-delta T cell activation (GO:0046643) | 2.54571286 |
| 115 | regulation of cholesterol storage (GO:0010885) | 2.54541581 |
| 116 | response to host defenses (GO:0052200) | 2.53756610 |
| 117 | response to defenses of other organism involved in symbiotic interaction (GO:0052173) | 2.53756610 |
| 118 | response to host (GO:0075136) | 2.53756610 |
| 119 | plasma lipoprotein particle clearance (GO:0034381) | 2.52835178 |
| 120 | production of molecular mediator involved in inflammatory response (GO:0002532) | 2.52691405 |
| 121 | positive regulation of antigen processing and presentation (GO:0002579) | 2.52179674 |
| 122 | myeloid cell activation involved in immune response (GO:0002275) | 2.50975841 |
| 123 | interferon-gamma-mediated signaling pathway (GO:0060333) | 2.50416841 |
| 124 | tryptophan catabolic process (GO:0006569) | 2.48794244 |
| 125 | indole-containing compound catabolic process (GO:0042436) | 2.48794244 |
| 126 | indolalkylamine catabolic process (GO:0046218) | 2.48794244 |
| 127 | neutrophil activation (GO:0042119) | 2.47935681 |
| 128 | cellular response to exogenous dsRNA (GO:0071360) | 2.47285628 |
| 129 | cellular response to interferon-beta (GO:0035458) | 2.46686706 |
| 130 | tryptophan metabolic process (GO:0006568) | 2.46572993 |
| 131 | mast cell activation (GO:0045576) | 2.44685154 |
| 132 | hydrogen peroxide biosynthetic process (GO:0050665) | 2.41945477 |
| 133 | aromatic amino acid family catabolic process (GO:0009074) | 2.40608764 |
| 134 | positive regulation of natural killer cell differentiation (GO:0032825) | 2.40124343 |
| 135 | granulocyte activation (GO:0036230) | 2.39014119 |
| 136 | neutrophil mediated immunity (GO:0002446) | 2.38905535 |
| 137 | phospholipid efflux (GO:0033700) | 2.38534235 |
| 138 | angiogenesis involved in wound healing (GO:0060055) | 2.36879348 |
| 139 | positive regulation of macrophage differentiation (GO:0045651) | 2.35769906 |
| 140 | negative regulation of myeloid cell apoptotic process (GO:0033033) | 2.35484989 |
| 141 | positive regulation of coagulation (GO:0050820) | 2.34452489 |
| 142 | negative regulation of erythrocyte differentiation (GO:0045647) | 2.34291551 |
| 143 | microglial cell activation (GO:0001774) | 2.33841021 |
| 144 | valine metabolic process (GO:0006573) | 2.33794492 |
| 145 | complement activation (GO:0006956) | 2.33583530 |
| 146 | regulation of humoral immune response mediated by circulating immunoglobulin (GO:0002923) | 2.31694784 |
| 147 | negative regulation of interleukin-17 production (GO:0032700) | 2.31652094 |
| 148 | opsonization (GO:0008228) | 2.31645760 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | IRF8_22096565_ChIP-ChIP_GC-B_Human | 4.95185261 |
| 2 | ESR1_17901129_ChIP-ChIP_LIVER_Mouse | 4.31400636 |
| 3 | IRF8_21731497_ChIP-ChIP_J774_Mouse | 4.07095899 |
| 4 | BP1_19119308_ChIP-ChIP_Hs578T_Human | 4.06817133 |
| 5 | IRF8_22096565_ChIP-ChIP_GC-B_Mouse | 3.22726353 |
| 6 | MECOM_23826213_ChIP-Seq_KASUMI_Mouse | 3.21567728 |
| 7 | IRF1_21803131_ChIP-Seq_MONOCYTES_Human | 3.07487653 |
| 8 | * RXR_22158963_ChIP-Seq_LIVER_Mouse | 3.07300987 |
| 9 | * SMRT_22465074_ChIP-Seq_MACROPHAGES_Mouse | 3.04707632 |
| 10 | * IRF8_27001747_Chip-Seq_BMDM_Mouse | 3.04308517 |
| 11 | * NCOR_22465074_ChIP-Seq_MACROPHAGES_Mouse | 2.93298324 |
| 12 | MYB_21317192_ChIP-Seq_ERMYB_Mouse | 2.90524448 |
| 13 | PPARG_19300518_ChIP-PET_3T3-L1_Mouse | 2.90046455 |
| 14 | PPARA_22158963_ChIP-Seq_LIVER_Mouse | 2.79991997 |
| 15 | STAT6_20620947_ChIP-Seq_CD4_POS_T_Human | 2.78347132 |
| 16 | GATA1_22025678_ChIP-Seq_K562_Human | 2.78078717 |
| 17 | EGR1_23403033_ChIP-Seq_LIVER_Mouse | 2.76838920 |
| 18 | FOXP3_17237761_ChIP-ChIP_TREG_Mouse | 2.71223826 |
| 19 | * SCL_19346495_ChIP-Seq_HPC-7_Human | 2.62573012 |
| 20 | NR1H3_23393188_ChIP-Seq_ATHEROSCLEROTIC-FOAM_Human | 2.51604127 |
| 21 | * RUNX1_20887958_ChIP-Seq_HPC-7_Mouse | 2.40413782 |
| 22 | SPI1_22096565_ChIP-ChIP_GC-B_Mouse | 2.35882471 |
| 23 | LXR_22158963_ChIP-Seq_LIVER_Mouse | 2.28659864 |
| 24 | CEBPA_23403033_ChIP-Seq_LIVER_Mouse | 2.26133970 |
| 25 | EGR1_19374776_ChIP-ChIP_THP-1_Human | 2.24238877 |
| 26 | * BRD4_27068464_Chip-Seq_AML-cells_Mouse | 2.14632759 |
| 27 | * STAT4_19710469_ChIP-ChIP_TH1__Mouse | 2.14415468 |
| 28 | VDR_21846776_ChIP-Seq_THP-1_Human | 2.05962325 |
| 29 | Nerf2_26677805_Chip-Seq_MACROPHAGESS_Mouse | 2.05272228 |
| 30 | STAT3_20064451_ChIP-Seq_CD4+T_Mouse | 2.00541701 |
| 31 | SPI1_23547873_ChIP-Seq_NB4_Human | 2.00318175 |
| 32 | VDR_23401126_ChIP-Seq_LCL-AND-THP1_Human | 1.97637203 |
| 33 | SPI1_22790984_ChIP-Seq_ERYTHROLEUKEMIA_Mouse | 1.96106406 |
| 34 | * RELA_24523406_ChIP-Seq_FIBROSARCOMA_Human | 1.94650540 |
| 35 | * NUCKS1_24931609_ChIP-Seq_HEPATOCYTES_Mouse | 1.89900359 |
| 36 | VDR_24763502_ChIP-Seq_THP-1_Human | 1.87194908 |
| 37 | CEBPB_23403033_ChIP-Seq_LIVER_Mouse | 1.83547359 |
| 38 | RUNX1_22412390_ChIP-Seq_EML_Mouse | 1.77893626 |
| 39 | * MAF_26560356_Chip-Seq_TH1_Human | 1.76987439 |
| 40 | FLI1_20887958_ChIP-Seq_HPC-7_Mouse | 1.76557268 |
| 41 | * MYB_26560356_Chip-Seq_TH2_Human | 1.75888943 |
| 42 | STAT3_22323479_ChIP-Seq_MACROPHAGE_Mouse | 1.75778682 |
| 43 | RUNX_20019798_ChIP-Seq_JUKART_Human | 1.71858276 |
| 44 | ASXL1_24218140_ChIP-Seq_BMDM_Mouse | 1.67036945 |
| 45 | FOXO1_23066095_ChIP-Seq_LIVER_Mouse | 1.65872721 |
| 46 | SMAD_19615063_ChIP-ChIP_OVARY_Human | 1.65017984 |
| 47 | * STAT5_23275557_ChIP-Seq_MAMMARY-EPITHELIUM_Mouse | 1.63904798 |
| 48 | MYC_22102868_ChIP-Seq_BL_Human | 1.57108698 |
| 49 | FOXO1_25302145_ChIP-Seq_T-LYMPHOCYTE_Mouse | 1.56537537 |
| 50 | CIITA_18437201_ChIP-ChIP_Raji_B_and_iDC_Human | 1.54908613 |
| 51 | * LYL1_20887958_ChIP-Seq_HPC-7_Mouse | 1.54734460 |
| 52 | * MYB_26560356_Chip-Seq_TH1_Human | 1.54702313 |
| 53 | * MEIS1_20887958_ChIP-Seq_HPC-7_Mouse | 1.53691252 |
| 54 | E2F7_22180533_ChIP-Seq_HELA_Human | 1.53618391 |
| 55 | * LMO2_20887958_ChIP-Seq_HPC-7_Mouse | 1.50756603 |
| 56 | GATA1_22383799_ChIP-Seq_G1ME_Mouse | 1.49792475 |
| 57 | TAL1_20887958_ChIP-Seq_HPC-7_Mouse | 1.47174106 |
| 58 | KDM2B_26808549_Chip-Seq_SUP-B15_Human | 1.46292559 |
| 59 | CEBPB_20176806_ChIP-Seq_THIOMACROPHAGE_Mouse | 1.45527105 |
| 60 | PU_27001747_Chip-Seq_BMDM_Mouse | 1.43528017 |
| 61 | SPI1_23127762_ChIP-Seq_K562_Human | 1.42980748 |
| 62 | * GATA2_22383799_ChIP-Seq_G1ME_Mouse | 1.41018546 |
| 63 | UTX_26944678_Chip-Seq_JUKART_Human | 1.38502993 |
| 64 | EKLF_21900194_ChIP-Seq_ERYTHROCYTE_Mouse | 1.37827627 |
| 65 | * E2A_27217539_Chip-Seq_RAMOS-Cell_line_Human | 1.37583369 |
| 66 | TAF7L_23326641_ChIP-Seq_C3H10T1-2_Mouse | 1.35917294 |
| 67 | SFPI1_20887958_ChIP-Seq_HPC-7_Mouse | 1.31728511 |
| 68 | CEBPB_20176806_ChIP-Seq_MACROPHAGES_Mouse | 1.31563576 |
| 69 | KDM2B_26808549_Chip-Seq_DND41_Human | 1.29487179 |
| 70 | * TCF7_22412390_ChIP-Seq_EML_Mouse | 1.28269336 |
| 71 | THRA_23701648_ChIP-Seq_CEREBELLUM_Mouse | 1.27978669 |
| 72 | * GATA2_20887958_ChIP-Seq_HPC-7_Mouse | 1.27337872 |
| 73 | KDM2B_26808549_Chip-Seq_HPB-ALL_Human | 1.24021083 |
| 74 | GATA1_19941827_ChIP-Seq_MEL_Mouse | 1.23192540 |
| 75 | * ERG_20887958_ChIP-Seq_HPC-7_Mouse | 1.22525759 |
| 76 | * TAL1_20566737_ChIP-Seq_PRIMARY_FETAL_LIVER_ERYTHROID_Mouse | 1.22231653 |
| 77 | GATA2_21666600_ChIP-Seq_HMVEC_Human | 1.21052588 |
| 78 | ELK3_25401928_ChIP-Seq_HUVEC_Human | 1.18743229 |
| 79 | * PPARG_20176806_ChIP-Seq_THIOMACROPHAGE_Mouse | 1.13552788 |
| 80 | CEBPB_21427703_ChIP-Seq_3T3-L1_Mouse | 1.13531915 |
| 81 | CEBPB_20513432_ChIP-Seq_MACROPHAGES_Mouse | 1.13471950 |
| 82 | NFE2L2_22581777_ChIP-Seq_LYMPHOBLASTOID_Human | 1.11887817 |
| 83 | CLOCK_20551151_ChIP-Seq_293T_Human | 1.11729527 |
| 84 | GATA3_27048872_Chip-Seq_THYMUS_Human | 1.09048173 |
| 85 | TRP63_18441228_ChIP-ChIP_KERATINOCYTES_Mouse | 1.08889116 |
| 86 | ELF1_17652178_ChIP-ChIP_JURKAT_Human | 1.07492230 |
| 87 | CEBPA_20513432_ChIP-Seq_MACROPHAGES_Mouse | 1.06273191 |
| 88 | RARG_19884340_ChIP-ChIP_MEFs_Mouse | 1.05836442 |
| 89 | VDR_20736230_ChIP-Seq_LYMPHOBLASTOID_Human | 1.05739765 |
| 90 | SCL_21571218_ChIP-Seq_MEGAKARYOCYTES_Human | 1.05689262 |
| 91 | GATA1_19941826_ChIP-Seq_K562_Human | 1.04901720 |
| 92 | GFI1B_20887958_ChIP-Seq_HPC-7_Mouse | 1.04824679 |
| 93 | NR1I2_20693526_ChIP-Seq_LIVER_Mouse | 1.04129641 |
| 94 | MAF_26560356_Chip-Seq_TH2_Human | 1.03506057 |
| 95 | NOTCH1_21737748_ChIP-Seq_TLL_Human | 1.03314100 |
| 96 | PU.1_20513432_ChIP-Seq_MACROPHAGES_Mouse | 1.02358359 |
| 97 | PU.1_20176806_ChIP-Seq_MACROPHAGES_Mouse | 1.02293978 |
| 98 | HOXB4_20404135_ChIP-ChIP_EML_Mouse | 1.02119621 |
| 99 | SOX9_22984422_ChIP-ChIP_TESTIS_Rat | 1.00274524 |
| 100 | * GATA1_21571218_ChIP-Seq_MEGAKARYOCYTES_Human | 0.99717644 |
| 101 | * PPARG_20176806_ChIP-Seq_MACROPHAGES_Mouse | 0.99488620 |
| 102 | BCL6_27268052_Chip-Seq_Bcells_Human | 0.96998641 |
| 103 | PU.1_20513432_ChIP-Seq_Bcells_Mouse | 0.96654894 |
| 104 | GATA2_19941826_ChIP-Seq_K562_Human | 0.95146247 |
| 105 | GATA2_21571218_ChIP-Seq_MEGAKARYOCYTES_Human | 0.94808474 |
| 106 | IKZF1_21737484_ChIP-ChIP_HCT116_Human | 0.93588449 |
| 107 | * SPI1_20176806_ChIP-Seq_THIOMACROPHAGE_Mouse | 0.92953615 |
| 108 | VDR_24787735_ChIP-Seq_THP-1_Human | 0.92893597 |
| 109 | * GATA3_26560356_Chip-Seq_TH2_Human | 0.90783025 |
| 110 | TCF21_26020271_ChIP-Seq_SMOOTH_MUSCLE_Human | 0.89276338 |
| 111 | HNF4A_19761587_ChIP-ChIP_CACO-2_Human | 0.88637186 |
| 112 | TBP_23326641_ChIP-Seq_C3H10T1-2_Mouse | 0.87124321 |
| 113 | SPI1_20517297_ChIP-Seq_HL60_Human | 0.85406755 |
| 114 | BCOR_27268052_Chip-Seq_Bcells_Human | 0.85070214 |
| 115 | STAT1_20625510_ChIP-Seq_HELA_Human | 0.83618412 |
| 116 | LXR_22292898_ChIP-Seq_THP-1_Human | 0.83343904 |
| 117 | KDM2B_26808549_Chip-Seq_SIL-ALL_Human | 0.82955592 |
| 118 | SMRT_27268052_Chip-Seq_Bcells_Human | 0.79768736 |
| 119 | TFEB_21752829_ChIP-Seq_HELA_Human | 0.79456381 |
| 120 | NCOR1_26117541_ChIP-Seq_K562_Human | 0.79219702 |
| 121 | KDM2B_26808549_Chip-Seq_JURKAT_Human | 0.77426836 |
| 122 | RUNX1_21571218_ChIP-Seq_MEGAKARYOCYTES_Human | 0.76599378 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | MP0001835_abnormal_antigen_presentation | 3.35325543 |
| 2 | MP0003724_increased_susceptibility_to | 2.92683695 |
| 3 | MP0003436_decreased_susceptibility_to | 2.91172187 |
| 4 | MP0009785_altered_susceptibility_to | 2.78359048 |
| 5 | MP0003303_peritoneal_inflammation | 2.54739074 |
| 6 | MP0002139_abnormal_hepatobiliary_system | 2.50408815 |
| 7 | MP0003191_abnormal_cellular_cholesterol | 2.49070393 |
| 8 | * MP0002419_abnormal_innate_immunity | 2.46164823 |
| 9 | MP0005360_urolithiasis | 2.38412649 |
| 10 | * MP0005025_abnormal_response_to | 2.35008405 |
| 11 | MP0000685_abnormal_immune_system | 2.34607664 |
| 12 | MP0005365_abnormal_bile_salt | 2.28814793 |
| 13 | MP0005464_abnormal_platelet_physiology | 2.27418011 |
| 14 | MP0009840_abnormal_foam_cell | 2.23786134 |
| 15 | MP0002148_abnormal_hypersensitivity_rea | 2.19585250 |
| 16 | MP0005058_abnormal_lysosome_morphology | 2.19227541 |
| 17 | MP0005000_abnormal_immune_tolerance | 2.18574320 |
| 18 | MP0005671_abnormal_response_to | 2.10343705 |
| 19 | MP0002396_abnormal_hematopoietic_system | 2.06883874 |
| 20 | * MP0001800_abnormal_humoral_immune | 2.04119672 |
| 21 | MP0005387_immune_system_phenotype | 2.03067827 |
| 22 | MP0001790_abnormal_immune_system | 2.03067827 |
| 23 | * MP0002452_abnormal_antigen_presenting | 2.00016740 |
| 24 | * MP0002723_abnormal_immune_serum | 1.96157479 |
| 25 | MP0005085_abnormal_gallbladder_physiolo | 1.95437189 |
| 26 | MP0002166_altered_tumor_susceptibility | 1.93525542 |
| 27 | MP0006082_CNS_inflammation | 1.92884027 |
| 28 | MP0008875_abnormal_xenobiotic_pharmacok | 1.82319848 |
| 29 | * MP0002420_abnormal_adaptive_immunity | 1.79357085 |
| 30 | MP0003300_gastrointestinal_ulcer | 1.79033614 |
| 31 | * MP0001819_abnormal_immune_cell | 1.78480923 |
| 32 | MP0001853_heart_inflammation | 1.75627313 |
| 33 | MP0008469_abnormal_protein_level | 1.75460740 |
| 34 | MP0005397_hematopoietic_system_phenotyp | 1.71194366 |
| 35 | MP0001545_abnormal_hematopoietic_system | 1.71194366 |
| 36 | MP0001533_abnormal_skeleton_physiology | 1.69435455 |
| 37 | MP0001845_abnormal_inflammatory_respons | 1.67504597 |
| 38 | MP0002405_respiratory_system_inflammati | 1.59052741 |
| 39 | MP0010329_abnormal_lipoprotein_level | 1.58457338 |
| 40 | MP0009764_decreased_sensitivity_to | 1.58023724 |
| 41 | MP0002006_tumorigenesis | 1.56595717 |
| 42 | MP0010155_abnormal_intestine_physiology | 1.53586258 |
| 43 | MP0003252_abnormal_bile_duct | 1.53041861 |
| 44 | MP0003656_abnormal_erythrocyte_physiolo | 1.52414402 |
| 45 | MP0000343_altered_response_to | 1.50704652 |
| 46 | MP0005451_abnormal_body_composition | 1.48150665 |
| 47 | MP0002398_abnormal_bone_marrow | 1.47930558 |
| 48 | MP0005310_abnormal_salivary_gland | 1.47099737 |
| 49 | MP0000689_abnormal_spleen_morphology | 1.44846100 |
| 50 | * MP0000716_abnormal_immune_system | 1.44348259 |
| 51 | MP0009278_abnormal_bone_marrow | 1.41655785 |
| 52 | MP0000609_abnormal_liver_physiology | 1.39104947 |
| 53 | MP0003186_abnormal_redox_activity | 1.38802837 |
| 54 | MP0004947_skin_inflammation | 1.35558499 |
| 55 | MP0008260_abnormal_autophagy | 1.34899281 |
| 56 | MP0006054_spinal_hemorrhage | 1.33712208 |
| 57 | MP0003763_abnormal_thymus_physiology | 1.28734481 |
| 58 | MP0002722_abnormal_immune_system | 1.28655204 |
| 59 | MP0009763_increased_sensitivity_to | 1.27747456 |
| 60 | * MP0002429_abnormal_blood_cell | 1.27150666 |
| 61 | MP0004808_abnormal_hematopoietic_stem | 1.26086403 |
| 62 | MP0000703_abnormal_thymus_morphology | 1.25090463 |
| 63 | MP0009333_abnormal_splenocyte_physiolog | 1.24886473 |
| 64 | MP0008438_abnormal_cutaneous_collagen | 1.24638046 |
| 65 | MP0005083_abnormal_biliary_tract | 1.23586580 |
| 66 | MP0003172_abnormal_lysosome_physiology | 1.22005980 |
| 67 | MP0003183_abnormal_peptide_metabolism | 1.21328070 |
| 68 | MP0000465_gastrointestinal_hemorrhage | 1.19062025 |
| 69 | MP0005319_abnormal_enzyme/_coenzyme | 1.18129519 |
| 70 | MP0003806_abnormal_nucleotide_metabolis | 1.17679046 |
| 71 | MP0000858_altered_metastatic_potential | 1.17598622 |
| 72 | MP0003075_altered_response_to | 1.17462983 |
| 73 | MP0002132_abnormal_respiratory_system | 1.12291022 |
| 74 | MP0001873_stomach_inflammation | 1.08331745 |
| 75 | MP0010368_abnormal_lymphatic_system | 1.04874551 |
| 76 | MP0002933_joint_inflammation | 1.04629136 |
| 77 | MP0002998_abnormal_bone_remodeling | 1.03951519 |
| 78 | MP0003448_altered_tumor_morphology | 1.03947626 |
| 79 | MP0004883_abnormal_blood_vessel | 1.03494280 |
| 80 | MP0005584_abnormal_enzyme/coenzyme_acti | 1.02844593 |
| 81 | MP0000598_abnormal_liver_morphology | 1.01239170 |
| 82 | MP0000249_abnormal_blood_vessel | 1.01098077 |
| 83 | MP0002277_abnormal_respiratory_mucosa | 1.00597492 |
| 84 | MP0003690_abnormal_glial_cell | 1.00397003 |
| 85 | MP0002138_abnormal_hepatobiliary_system | 1.00231426 |
| 86 | MP0008004_abnormal_stomach_pH | 0.99936483 |
| 87 | MP0004510_myositis | 0.97309074 |
| 88 | MP0004381_abnormal_hair_follicle | 0.94992371 |
| 89 | MP0005023_abnormal_wound_healing | 0.94644090 |
| 90 | MP0003828_pulmonary_edema | 0.92872716 |
| 91 | MP0001663_abnormal_digestive_system | 0.89429419 |
| 92 | MP0005164_abnormal_response_to | 0.89391745 |
| 93 | MP0002118_abnormal_lipid_homeostasis | 0.89377338 |
| 94 | MP0005075_abnormal_melanosome_morpholog | 0.88909468 |
| 95 | MP0005174_abnormal_tail_pigmentation | 0.87246101 |
| 96 | MP0003195_calcinosis | 0.86089045 |
| 97 | MP0003279_aneurysm | 0.85858902 |
| 98 | MP0009697_abnormal_copulation | 0.85305237 |
| 99 | MP0000604_amyloidosis | 0.84365963 |
| 100 | MP0005167_abnormal_blood-brain_barrier | 0.84113300 |
| 101 | MP0000371_diluted_coat_color | 0.83716706 |
| 102 | MP0009643_abnormal_urine_homeostasis | 0.83286968 |
| 103 | MP0005166_decreased_susceptibility_to | 0.82934429 |
| 104 | MP0001879_abnormal_lymphatic_vessel | 0.82680898 |
| 105 | MP0005390_skeleton_phenotype | 0.79133063 |
| 106 | MP0000490_abnormal_crypts_of | 0.78885202 |
| 107 | MP0005332_abnormal_amino_acid | 0.78553937 |
| 108 | MP0001666_abnormal_nutrient_absorption | 0.77569392 |
| 109 | MP0001851_eye_inflammation | 0.77140721 |
| 110 | MP0002254_reproductive_system_inflammat | 0.76268295 |
| 111 | MP0003866_abnormal_defecation | 0.74794914 |
| 112 | MP0002136_abnormal_kidney_physiology | 0.74360731 |
| 113 | MP0004147_increased_porphyrin_level | 0.73995877 |
| 114 | MP0003045_fibrosis | 0.71427375 |
| 115 | MP0009765_abnormal_xenobiotic_induced | 0.70473977 |
| 116 | MP0003795_abnormal_bone_structure | 0.65592952 |
| 117 | MP0000015_abnormal_ear_pigmentation | 0.58891071 |
| 118 | MP0002009_preneoplasia | 0.57598148 |
| 119 | MP0002332_abnormal_exercise_endurance | 0.55602553 |
| 120 | MP0003091_abnormal_cell_migration | 0.54825479 |
| 121 | MP0008874_decreased_physiological_sensi | 0.54010969 |
| 122 | MP0002693_abnormal_pancreas_physiology | 0.53377293 |
| 123 | MP0003453_abnormal_keratinocyte_physiol | 0.48817565 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | Recurrent abscess formation (HP:0002722) | 4.80696553 |
| 2 | Recurrent bacterial skin infections (HP:0005406) | 4.66027869 |
| 3 | Systemic lupus erythematosus (HP:0002725) | 4.36360983 |
| 4 | Eczematoid dermatitis (HP:0000976) | 4.31364074 |
| 5 | Recurrent gram-negative bacterial infections (HP:0005420) | 4.24345635 |
| 6 | Elevated erythrocyte sedimentation rate (HP:0003565) | 4.01894408 |
| 7 | Myositis (HP:0100614) | 3.92295921 |
| 8 | Keratoconjunctivitis sicca (HP:0001097) | 3.91871411 |
| 9 | Complement deficiency (HP:0004431) | 3.84859634 |
| 10 | Keratoconjunctivitis (HP:0001096) | 3.61819244 |
| 11 | Encephalitis (HP:0002383) | 3.57227875 |
| 12 | Abnormality of liposaccharide metabolism (HP:0010968) | 3.57067334 |
| 13 | Abnormality of glycosphingolipid metabolism (HP:0004343) | 3.57067334 |
| 14 | Abnormality of glycolipid metabolism (HP:0010969) | 3.57067334 |
| 15 | Glomerulonephritis (HP:0000099) | 3.50725956 |
| 16 | T lymphocytopenia (HP:0005403) | 3.45806418 |
| 17 | Recurrent skin infections (HP:0001581) | 3.39458174 |
| 18 | Joint hemorrhage (HP:0005261) | 3.38725213 |
| 19 | Abnormality of T cell number (HP:0011839) | 3.38589587 |
| 20 | Vacuolated lymphocytes (HP:0001922) | 3.36570277 |
| 21 | Prolonged partial thromboplastin time (HP:0003645) | 3.26551052 |
| 22 | Spontaneous hematomas (HP:0007420) | 3.24868684 |
| 23 | Abnormality of complement system (HP:0005339) | 3.23660287 |
| 24 | Chronic otitis media (HP:0000389) | 3.20983138 |
| 25 | Abnormality of macrophages (HP:0004311) | 3.09575735 |
| 26 | Thrombocytosis (HP:0001894) | 3.09186729 |
| 27 | Deep venous thrombosis (HP:0002625) | 3.01059353 |
| 28 | Increased IgE level (HP:0003212) | 3.00962144 |
| 29 | Recurrent viral infections (HP:0004429) | 2.95203721 |
| 30 | Autoimmune thrombocytopenia (HP:0001973) | 2.92189122 |
| 31 | Leukocytosis (HP:0001974) | 2.89281223 |
| 32 | Recurrent fungal infections (HP:0002841) | 2.87763787 |
| 33 | Gingival bleeding (HP:0000225) | 2.86368260 |
| 34 | Colitis (HP:0002583) | 2.84892577 |
| 35 | Abnormality of the common coagulation pathway (HP:0010990) | 2.82043142 |
| 36 | Epistaxis (HP:0000421) | 2.80269125 |
| 37 | Mediastinal lymphadenopathy (HP:0100721) | 2.79439783 |
| 38 | Granulocytopenia (HP:0001913) | 2.78044450 |
| 39 | Gangrene (HP:0100758) | 2.76199253 |
| 40 | Myocardial infarction (HP:0001658) | 2.73461442 |
| 41 | Anorexia (HP:0002039) | 2.69246206 |
| 42 | Increased IgM level (HP:0003496) | 2.66661212 |
| 43 | Increased cerebral lipofuscin (HP:0011813) | 2.66064357 |
| 44 | Abnormality of aromatic amino acid family metabolism (HP:0004338) | 2.65351462 |
| 45 | Xanthomatosis (HP:0000991) | 2.65205930 |
| 46 | Orchitis (HP:0100796) | 2.64434634 |
| 47 | Pustule (HP:0200039) | 2.63982826 |
| 48 | Abnormal delayed hypersensitivity skin test (HP:0002963) | 2.61719610 |
| 49 | Chest pain (HP:0100749) | 2.61236574 |
| 50 | Dysostosis multiplex (HP:0000943) | 2.60603077 |
| 51 | Eosinophilia (HP:0001880) | 2.60292638 |
| 52 | Increased neuronal autofluorescent lipopigment (HP:0002074) | 2.59353485 |
| 53 | Abnormality of the pleura (HP:0002103) | 2.58284817 |
| 54 | Inflammation of the large intestine (HP:0002037) | 2.53203483 |
| 55 | Polyneuropathy (HP:0001271) | 2.49643336 |
| 56 | Meningitis (HP:0001287) | 2.48840452 |
| 57 | Interstitial pulmonary disease (HP:0006530) | 2.48093315 |
| 58 | Abnormality of monocarboxylic acid metabolism (HP:0010996) | 2.47466025 |
| 59 | Impaired platelet aggregation (HP:0003540) | 2.46571735 |
| 60 | Abnormal platelet function (HP:0011869) | 2.46571735 |
| 61 | Prolonged bleeding time (HP:0003010) | 2.45411291 |
| 62 | Recurrent cutaneous fungal infections (HP:0011370) | 2.44212675 |
| 63 | Chronic mucocutaneous candidiasis (HP:0002728) | 2.44212675 |
| 64 | Periodontitis (HP:0000704) | 2.44011016 |
| 65 | Nephritis (HP:0000123) | 2.43966410 |
| 66 | Gastrointestinal inflammation (HP:0004386) | 2.43706511 |
| 67 | Abnormality of the nasal mucosa (HP:0000433) | 2.43529731 |
| 68 | Mucopolysacchariduria (HP:0008155) | 2.41262824 |
| 69 | Urinary glycosaminoglycan excretion (HP:0003541) | 2.41262824 |
| 70 | Autoimmune hemolytic anemia (HP:0001890) | 2.40965828 |
| 71 | Cellulitis (HP:0100658) | 2.38223085 |
| 72 | Petechiae (HP:0000967) | 2.34439822 |
| 73 | Abnormality of T cell physiology (HP:0011840) | 2.33147848 |
| 74 | Gastrointestinal stroma tumor (HP:0100723) | 2.32287635 |
| 75 | Hypergammaglobulinemia (HP:0010702) | 2.32009051 |
| 76 | IgM deficiency (HP:0002850) | 2.31032167 |
| 77 | Axonal loss (HP:0003447) | 2.29947334 |
| 78 | Urticaria (HP:0001025) | 2.29566764 |
| 79 | Vasculitis (HP:0002633) | 2.29346113 |
| 80 | Reduced antithrombin III activity (HP:0001976) | 2.29318559 |
| 81 | Amyloidosis (HP:0011034) | 2.28561145 |
| 82 | Hematochezia (HP:0002573) | 2.28241043 |
| 83 | Gingivitis (HP:0000230) | 2.28129920 |
| 84 | Panhypogammaglobulinemia (HP:0003139) | 2.27511756 |
| 85 | Lymphopenia (HP:0001888) | 2.27016217 |
| 86 | Abnormality of mucopolysaccharide metabolism (HP:0011020) | 2.26309771 |
| 87 | Abnormality of polysaccharide metabolism (HP:0011012) | 2.26309771 |
| 88 | Abnormality of glycosaminoglycan metabolism (HP:0004371) | 2.26309771 |
| 89 | Thrombophlebitis (HP:0004418) | 2.25907182 |
| 90 | Joint swelling (HP:0001386) | 2.25623532 |
| 91 | Abnormality of eosinophils (HP:0001879) | 2.22896447 |
| 92 | Hyperlipoproteinemia (HP:0010980) | 2.21897798 |
| 93 | Intrahepatic cholestasis (HP:0001406) | 2.21696713 |
| 94 | Glomerulopathy (HP:0100820) | 2.20648093 |
| 95 | Arterial thrombosis (HP:0004420) | 2.20520663 |
| 96 | Nasal polyposis (HP:0100582) | 2.19811465 |
| 97 | Obstructive lung disease (HP:0006536) | 2.19797529 |
| 98 | Chronic obstructive pulmonary disease (HP:0006510) | 2.19797529 |
| 99 | Abnormality of cells of the lymphoid lineage (HP:0012140) | 2.18861091 |
| 100 | Pulmonary embolism (HP:0002204) | 2.18546406 |
| 101 | Microcytic anemia (HP:0001935) | 2.17916254 |
| 102 | Episodic fever (HP:0001954) | 2.17703738 |
| 103 | Purpura (HP:0000979) | 2.17419741 |
| 104 | Loss of speech (HP:0002371) | 2.17358131 |
| 105 | Abnormality of the prostate (HP:0008775) | 2.14777744 |
| 106 | Esophageal varix (HP:0002040) | 2.14068892 |
| 107 | Recurrent sinusitis (HP:0011108) | 2.13392330 |
| 108 | Vertigo (HP:0002321) | 2.12884240 |
| 109 | Keratitis (HP:0000491) | 2.10587375 |
| 110 | IgG deficiency (HP:0004315) | 2.07850670 |
| 111 | Abnormality of B cell number (HP:0010975) | 2.05235835 |
| 112 | Menorrhagia (HP:0000132) | 2.05051580 |
| 113 | Stomatitis (HP:0010280) | 2.04945238 |
| 114 | Acne (HP:0001061) | 2.04451739 |
| 115 | Polycythemia (HP:0001901) | 2.04046276 |
| 116 | Restrictive lung disease (HP:0002091) | 2.03363218 |
| 117 | Premature loss of primary teeth (HP:0006323) | 2.03228280 |
| 118 | Abnormality of the endocardium (HP:0004306) | 2.03073246 |
| 119 | Parkinsonism with favorable response to dopaminergic medication (HP:0002548) | 2.01964410 |
| 120 | Hypercholesterolemia (HP:0003124) | 2.01420234 |
| 121 | Basal ganglia calcification (HP:0002135) | 2.00859726 |
| 122 | Pulmonary infiltrates (HP:0002113) | 1.99767625 |
| 123 | Abnormality of iron homeostasis (HP:0011031) | 1.99726552 |
| 124 | Nonimmune hydrops fetalis (HP:0001790) | 1.99618080 |
| 125 | Osteomyelitis (HP:0002754) | 1.99140155 |
| 126 | Abnormality of the intrinsic pathway (HP:0010989) | 1.97912535 |
| 127 | Agammaglobulinemia (HP:0004432) | 1.97891245 |
| 128 | Increased serum ferritin (HP:0003281) | 1.97503667 |
| 129 | Gastrointestinal infarctions (HP:0005244) | 1.96773622 |
| 130 | Abnormality of T cells (HP:0002843) | 1.96072049 |
| 131 | Vertebral compression fractures (HP:0002953) | 1.95839228 |
| 132 | Thoracic kyphosis (HP:0002942) | 1.94953660 |
| 133 | Hemoptysis (HP:0002105) | 1.94038972 |
| 134 | Retrobulbar optic neuritis (HP:0100654) | 1.93865032 |
| 135 | Optic neuritis (HP:0100653) | 1.93865032 |
| 136 | Recurrent bronchitis (HP:0002837) | 1.93636862 |
| 137 | Peritonitis (HP:0002586) | 1.92071033 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | ERN1 | 3.21950296 |
| 2 | KIT | 3.07462022 |
| 3 | MAP4K1 | 2.90273554 |
| 4 | TBK1 | 2.88998032 |
| 5 | TGFBR2 | 2.82828619 |
| 6 | TYK2 | 2.71910605 |
| 7 | IRAK4 | 2.47980887 |
| 8 | PRPF4B | 2.38741843 |
| 9 | BLK | 2.26298322 |
| 10 | MAP2K3 | 2.24964752 |
| 11 | IKBKE | 2.22550244 |
| 12 | TEC | 2.21014427 |
| 13 | MAP3K14 | 2.20479775 |
| 14 | FLT3 | 2.19909941 |
| 15 | IRAK3 | 2.19108162 |
| 16 | JAK3 | 2.12336203 |
| 17 | ZAP70 | 2.05747293 |
| 18 | KDR | 1.91079942 |
| 19 | NME2 | 1.83885905 |
| 20 | CSF1R | 1.83136696 |
| 21 | BTK | 1.80244386 |
| 22 | TAOK3 | 1.77164438 |
| 23 | IKBKB | 1.74683147 |
| 24 | FGFR4 | 1.67830387 |
| 25 | RIPK4 | 1.56722436 |
| 26 | EEF2K | 1.55317797 |
| 27 | TNK2 | 1.55286030 |
| 28 | JAK1 | 1.55033121 |
| 29 | FGR | 1.54940728 |
| 30 | TAOK1 | 1.53729123 |
| 31 | NLK | 1.53000811 |
| 32 | TXK | 1.52261191 |
| 33 | TIE1 | 1.44696110 |
| 34 | BMPR2 | 1.43208679 |
| 35 | RPS6KA4 | 1.42676072 |
| 36 | BCKDK | 1.41367488 |
| 37 | CSK | 1.35524405 |
| 38 | STK10 | 1.35078184 |
| 39 | PIM2 | 1.28321078 |
| 40 | EPHB1 | 1.27233686 |
| 41 | TRIB3 | 1.26699609 |
| 42 | ITK | 1.25623651 |
| 43 | SYK | 1.21763739 |
| 44 | TAOK2 | 1.20809316 |
| 45 | SIK3 | 1.20350349 |
| 46 | NEK9 | 1.15481618 |
| 47 | PKN2 | 1.15055200 |
| 48 | LYN | 1.10082339 |
| 49 | LCK | 1.09815370 |
| 50 | TGFBR1 | 1.07707249 |
| 51 | FES | 1.06597751 |
| 52 | LRRK2 | 1.02897052 |
| 53 | JAK2 | 1.00288381 |
| 54 | HCK | 0.97058361 |
| 55 | TRPM7 | 0.95908778 |
| 56 | MATK | 0.95456295 |
| 57 | MAP3K6 | 0.95322206 |
| 58 | MAP3K13 | 0.94513385 |
| 59 | SIK1 | 0.93799744 |
| 60 | TNIK | 0.92789534 |
| 61 | PIM1 | 0.90464045 |
| 62 | MAPKAPK3 | 0.89777404 |
| 63 | CDC42BPA | 0.87177804 |
| 64 | CHUK | 0.86770382 |
| 65 | EIF2AK3 | 0.86318783 |
| 66 | MAP3K10 | 0.84369859 |
| 67 | GRK6 | 0.83325830 |
| 68 | RIPK1 | 0.82340097 |
| 69 | SCYL2 | 0.81138565 |
| 70 | CAMK1D | 0.80141224 |
| 71 | MAP3K11 | 0.78435899 |
| 72 | PRKCQ | 0.77701237 |
| 73 | FGFR3 | 0.77027436 |
| 74 | IRAK1 | 0.76462347 |
| 75 | EPHA3 | 0.76459939 |
| 76 | MAPK11 | 0.75973625 |
| 77 | IRAK2 | 0.74875374 |
| 78 | MAPK7 | 0.74687051 |
| 79 | PDK1 | 0.74652031 |
| 80 | CLK1 | 0.74078905 |
| 81 | PTK6 | 0.73145737 |
| 82 | SIK2 | 0.73122667 |
| 83 | PIK3CG | 0.69238480 |
| 84 | PAK4 | 0.68414113 |
| 85 | YES1 | 0.65880090 |
| 86 | TESK2 | 0.63422184 |
| 87 | HIPK2 | 0.61351000 |
| 88 | MAPK4 | 0.59348254 |
| 89 | STK4 | 0.57126939 |
| 90 | PDPK1 | 0.56184287 |
| 91 | MARK2 | 0.55837866 |
| 92 | KSR2 | 0.55143645 |
| 93 | CDK6 | 0.54608054 |
| 94 | CAMKK1 | 0.54427936 |
| 95 | MAP3K5 | 0.53460392 |
| 96 | MAPKAPK5 | 0.51698534 |
| 97 | MAP3K3 | 0.50744512 |
| 98 | ABL2 | 0.48216542 |
| 99 | EIF2AK2 | 0.46006412 |
| 100 | FYN | 0.45914876 |
| 101 | MARK3 | 0.45889267 |
| 102 | MYLK | 0.45709987 |
| 103 | MAPK12 | 0.44810051 |
| 104 | PRKG2 | 0.42753235 |
| 105 | PRKD2 | 0.42398421 |
| 106 | ABL1 | 0.41982502 |
| 107 | RPS6KA6 | 0.40618840 |
| 108 | CDK4 | 0.40270623 |
| 109 | PRKCD | 0.39827599 |
| 110 | ACVR1B | 0.38922130 |
| 111 | RPS6KB2 | 0.37402093 |
| 112 | MAPKAPK2 | 0.37243074 |
| 113 | PRKAA2 | 0.36864411 |
| 114 | TTN | 0.36761938 |
| 115 | CAMKK2 | 0.36632175 |
| 116 | GRK7 | 0.36543845 |
| 117 | MAP3K12 | 0.35859293 |
| 118 | MAP3K2 | 0.35731277 |
| 119 | MAP3K7 | 0.35678012 |
| 120 | ADRBK2 | 0.35597897 |
| 121 | MOS | 0.34615725 |
| 122 | MAP3K1 | 0.34375319 |
| 123 | MST1R | 0.32740400 |
| 124 | NUAK1 | 0.31507144 |
| 125 | RPS6KL1 | 0.29652590 |
| 126 | RPS6KC1 | 0.29652590 |
| 127 | * EGFR | 0.26229160 |
| 128 | * IGF1R | 0.26113395 |
| 129 | MAP2K6 | 0.24781212 |
| 130 | SGK3 | 0.24663024 |
| 131 | CDK19 | 0.23098191 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | Staphylococcus aureus infection_Homo sapiens_hsa05150 | 3.74055571 |
| 2 | Autoimmune thyroid disease_Homo sapiens_hsa05320 | 2.86964841 |
| 3 | Complement and coagulation cascades_Homo sapiens_hsa04610 | 2.56895625 |
| 4 | Leishmaniasis_Homo sapiens_hsa05140 | 2.53719912 |
| 5 | Primary bile acid biosynthesis_Homo sapiens_hsa00120 | 2.48959290 |
| 6 | Type I diabetes mellitus_Homo sapiens_hsa04940 | 2.39661115 |
| 7 | Caffeine metabolism_Homo sapiens_hsa00232 | 2.22160617 |
| 8 | Ascorbate and aldarate metabolism_Homo sapiens_hsa00053 | 2.10290878 |
| 9 | Pentose and glucuronate interconversions_Homo sapiens_hsa00040 | 2.00766957 |
| 10 | RIG-I-like receptor signaling pathway_Homo sapiens_hsa04622 | 1.93579404 |
| 11 | Glycosaminoglycan degradation_Homo sapiens_hsa00531 | 1.87412299 |
| 12 | * Toll-like receptor signaling pathway_Homo sapiens_hsa04620 | 1.85233828 |
| 13 | Pertussis_Homo sapiens_hsa05133 | 1.84319396 |
| 14 | NF-kappa B signaling pathway_Homo sapiens_hsa04064 | 1.73915545 |
| 15 | * Osteoclast differentiation_Homo sapiens_hsa04380 | 1.72804674 |
| 16 | Malaria_Homo sapiens_hsa05144 | 1.71649856 |
| 17 | Cytosolic DNA-sensing pathway_Homo sapiens_hsa04623 | 1.69474084 |
| 18 | Viral myocarditis_Homo sapiens_hsa05416 | 1.68656523 |
| 19 | T cell receptor signaling pathway_Homo sapiens_hsa04660 | 1.65664869 |
| 20 | Legionellosis_Homo sapiens_hsa05134 | 1.65131421 |
| 21 | Inflammatory bowel disease (IBD)_Homo sapiens_hsa05321 | 1.62678302 |
| 22 | Other glycan degradation_Homo sapiens_hsa00511 | 1.60914009 |
| 23 | * Measles_Homo sapiens_hsa05162 | 1.55524641 |
| 24 | Primary immunodeficiency_Homo sapiens_hsa05340 | 1.53155518 |
| 25 | Antigen processing and presentation_Homo sapiens_hsa04612 | 1.51717568 |
| 26 | Porphyrin and chlorophyll metabolism_Homo sapiens_hsa00860 | 1.50370244 |
| 27 | Drug metabolism - other enzymes_Homo sapiens_hsa00983 | 1.37144174 |
| 28 | Fatty acid degradation_Homo sapiens_hsa00071 | 1.35408262 |
| 29 | Tuberculosis_Homo sapiens_hsa05152 | 1.30911855 |
| 30 | Hematopoietic cell lineage_Homo sapiens_hsa04640 | 1.28643414 |
| 31 | B cell receptor signaling pathway_Homo sapiens_hsa04662 | 1.28593738 |
| 32 | NOD-like receptor signaling pathway_Homo sapiens_hsa04621 | 1.28347017 |
| 33 | Lysosome_Homo sapiens_hsa04142 | 1.27409400 |
| 34 | ABC transporters_Homo sapiens_hsa02010 | 1.27012880 |
| 35 | Tryptophan metabolism_Homo sapiens_hsa00380 | 1.26607005 |
| 36 | Arginine biosynthesis_Homo sapiens_hsa00220 | 1.26116115 |
| 37 | Peroxisome_Homo sapiens_hsa04146 | 1.23267447 |
| 38 | Intestinal immune network for IgA production_Homo sapiens_hsa04672 | 1.21159041 |
| 39 | Chemical carcinogenesis_Homo sapiens_hsa05204 | 1.20938037 |
| 40 | Drug metabolism - cytochrome P450_Homo sapiens_hsa00982 | 1.19577661 |
| 41 | PPAR signaling pathway_Homo sapiens_hsa03320 | 1.18006112 |
| 42 | * Herpes simplex infection_Homo sapiens_hsa05168 | 1.16040291 |
| 43 | * Influenza A_Homo sapiens_hsa05164 | 1.13793989 |
| 44 | Biosynthesis of unsaturated fatty acids_Homo sapiens_hsa01040 | 1.13347051 |
| 45 | Toxoplasmosis_Homo sapiens_hsa05145 | 1.12851371 |
| 46 | Selenocompound metabolism_Homo sapiens_hsa00450 | 1.10121996 |
| 47 | Chagas disease (American trypanosomiasis)_Homo sapiens_hsa05142 | 1.09579881 |
| 48 | Metabolism of xenobiotics by cytochrome P450_Homo sapiens_hsa00980 | 1.08023184 |
| 49 | Nitrogen metabolism_Homo sapiens_hsa00910 | 1.06968198 |
| 50 | TNF signaling pathway_Homo sapiens_hsa04668 | 1.04640288 |
| 51 | Histidine metabolism_Homo sapiens_hsa00340 | 1.03401026 |
| 52 | Nicotinate and nicotinamide metabolism_Homo sapiens_hsa00760 | 1.01327899 |
| 53 | Sulfur relay system_Homo sapiens_hsa04122 | 1.00875378 |
| 54 | * Jak-STAT signaling pathway_Homo sapiens_hsa04630 | 0.98056456 |
| 55 | Phenylalanine, tyrosine and tryptophan biosynthesis_Homo sapiens_hsa00400 | 0.97873426 |
| 56 | Glycosphingolipid biosynthesis - ganglio series_Homo sapiens_hsa00604 | 0.94292204 |
| 57 | Allograft rejection_Homo sapiens_hsa05330 | 0.93956319 |
| 58 | Starch and sucrose metabolism_Homo sapiens_hsa00500 | 0.93839740 |
| 59 | Steroid hormone biosynthesis_Homo sapiens_hsa00140 | 0.90911686 |
| 60 | * Cytokine-cytokine receptor interaction_Homo sapiens_hsa04060 | 0.90051661 |
| 61 | Acute myeloid leukemia_Homo sapiens_hsa05221 | 0.88324698 |
| 62 | Valine, leucine and isoleucine degradation_Homo sapiens_hsa00280 | 0.86606774 |
| 63 | * Natural killer cell mediated cytotoxicity_Homo sapiens_hsa04650 | 0.86205200 |
| 64 | Folate biosynthesis_Homo sapiens_hsa00790 | 0.85962963 |
| 65 | Apoptosis_Homo sapiens_hsa04210 | 0.85811841 |
| 66 | beta-Alanine metabolism_Homo sapiens_hsa00410 | 0.85067114 |
| 67 | Cell adhesion molecules (CAMs)_Homo sapiens_hsa04514 | 0.83717999 |
| 68 | Pentose phosphate pathway_Homo sapiens_hsa00030 | 0.82931356 |
| 69 | African trypanosomiasis_Homo sapiens_hsa05143 | 0.82650461 |
| 70 | Graft-versus-host disease_Homo sapiens_hsa05332 | 0.79956350 |
| 71 | Glycine, serine and threonine metabolism_Homo sapiens_hsa00260 | 0.79755017 |
| 72 | Hepatitis B_Homo sapiens_hsa05161 | 0.79702790 |
| 73 | Fatty acid metabolism_Homo sapiens_hsa01212 | 0.78718421 |
| 74 | Pantothenate and CoA biosynthesis_Homo sapiens_hsa00770 | 0.78231274 |
| 75 | Shigellosis_Homo sapiens_hsa05131 | 0.77217009 |
| 76 | Fc gamma R-mediated phagocytosis_Homo sapiens_hsa04666 | 0.76751276 |
| 77 | Leukocyte transendothelial migration_Homo sapiens_hsa04670 | 0.76272894 |
| 78 | Epstein-Barr virus infection_Homo sapiens_hsa05169 | 0.76177418 |
| 79 | Epithelial cell signaling in Helicobacter pylori infection_Homo sapiens_hsa05120 | 0.75925656 |
| 80 | Retinol metabolism_Homo sapiens_hsa00830 | 0.75117890 |
| 81 | Butirosin and neomycin biosynthesis_Homo sapiens_hsa00524 | 0.75038728 |
| 82 | Salmonella infection_Homo sapiens_hsa05132 | 0.74838279 |
| 83 | Asthma_Homo sapiens_hsa05310 | 0.72909975 |
| 84 | Prolactin signaling pathway_Homo sapiens_hsa04917 | 0.69693643 |
| 85 | Non-small cell lung cancer_Homo sapiens_hsa05223 | 0.66269149 |
| 86 | DNA replication_Homo sapiens_hsa03030 | 0.66146049 |
| 87 | Glycosphingolipid biosynthesis - globo series_Homo sapiens_hsa00603 | 0.65198495 |
| 88 | * Hepatitis C_Homo sapiens_hsa05160 | 0.63648256 |
| 89 | Phagosome_Homo sapiens_hsa04145 | 0.61108798 |
| 90 | AGE-RAGE signaling pathway in diabetic complications_Homo sapiens_hsa04933 | 0.60654962 |
| 91 | Glyoxylate and dicarboxylate metabolism_Homo sapiens_hsa00630 | 0.59782681 |
| 92 | Adipocytokine signaling pathway_Homo sapiens_hsa04920 | 0.59036402 |
| 93 | Platelet activation_Homo sapiens_hsa04611 | 0.57848241 |
| 94 | VEGF signaling pathway_Homo sapiens_hsa04370 | 0.57738968 |
| 95 | Chemokine signaling pathway_Homo sapiens_hsa04062 | 0.57072226 |
| 96 | SNARE interactions in vesicular transport_Homo sapiens_hsa04130 | 0.55459217 |
| 97 | Sphingolipid signaling pathway_Homo sapiens_hsa04071 | 0.55331079 |
| 98 | Neurotrophin signaling pathway_Homo sapiens_hsa04722 | 0.55019929 |
| 99 | Glycosaminoglycan biosynthesis - chondroitin sulfate / dermatan sulfate_Homo sapiens_hsa00532 | 0.54059526 |
| 100 | HTLV-I infection_Homo sapiens_hsa05166 | 0.53812030 |
| 101 | Fatty acid elongation_Homo sapiens_hsa00062 | 0.52436759 |
| 102 | Vitamin digestion and absorption_Homo sapiens_hsa04977 | 0.51954814 |
| 103 | Propanoate metabolism_Homo sapiens_hsa00640 | 0.51582861 |
| 104 | Glutathione metabolism_Homo sapiens_hsa00480 | 0.51308632 |
| 105 | Transcriptional misregulation in cancer_Homo sapiens_hsa05202 | 0.50416246 |
| 106 | Viral carcinogenesis_Homo sapiens_hsa05203 | 0.48046720 |
| 107 | Ubiquinone and other terpenoid-quinone biosynthesis_Homo sapiens_hsa00130 | 0.47932901 |
| 108 | N-Glycan biosynthesis_Homo sapiens_hsa00510 | 0.47597894 |
| 109 | One carbon pool by folate_Homo sapiens_hsa00670 | 0.47146940 |
| 110 | Fc epsilon RI signaling pathway_Homo sapiens_hsa04664 | 0.46115793 |
| 111 | Rheumatoid arthritis_Homo sapiens_hsa05323 | 0.46082449 |
| 112 | Amoebiasis_Homo sapiens_hsa05146 | 0.45740744 |
| 113 | Lysine degradation_Homo sapiens_hsa00310 | 0.45082842 |
| 114 | Chronic myeloid leukemia_Homo sapiens_hsa05220 | 0.44816734 |
| 115 | Pancreatic cancer_Homo sapiens_hsa05212 | 0.43454266 |
| 116 | Insulin resistance_Homo sapiens_hsa04931 | 0.43072878 |
| 117 | Renal cell carcinoma_Homo sapiens_hsa05211 | 0.39046365 |
| 118 | Endocytosis_Homo sapiens_hsa04144 | 0.38792533 |
| 119 | Carbohydrate digestion and absorption_Homo sapiens_hsa04973 | 0.38398157 |
| 120 | FoxO signaling pathway_Homo sapiens_hsa04068 | 0.37850694 |
| 121 | Amyotrophic lateral sclerosis (ALS)_Homo sapiens_hsa05014 | 0.36898626 |
| 122 | HIF-1 signaling pathway_Homo sapiens_hsa04066 | 0.36664756 |
| 123 | Dorso-ventral axis formation_Homo sapiens_hsa04320 | 0.35604392 |
| 124 | Systemic lupus erythematosus_Homo sapiens_hsa05322 | 0.28292914 |
| 125 | Type II diabetes mellitus_Homo sapiens_hsa04930 | 0.28258629 |
| 126 | Notch signaling pathway_Homo sapiens_hsa04330 | 0.27310689 |
| 127 | Phospholipase D signaling pathway_Homo sapiens_hsa04072 | 0.25847362 |
| 128 | GnRH signaling pathway_Homo sapiens_hsa04912 | 0.24874656 |
| 129 | MAPK signaling pathway_Homo sapiens_hsa04010 | 0.24485181 |
| 130 | Prion diseases_Homo sapiens_hsa05020 | 0.23686935 |
| 131 | Inflammatory mediator regulation of TRP channels_Homo sapiens_hsa04750 | 0.23405672 |
| 132 | Bladder cancer_Homo sapiens_hsa05219 | 0.20792490 |
| 133 | Collecting duct acid secretion_Homo sapiens_hsa04966 | 0.19034079 |
| 134 | Sphingolipid metabolism_Homo sapiens_hsa00600 | 0.17839014 |
| 135 | mTOR signaling pathway_Homo sapiens_hsa04150 | 0.17049168 |
| 136 | Arachidonic acid metabolism_Homo sapiens_hsa00590 | 0.15599529 |
| 137 | Choline metabolism in cancer_Homo sapiens_hsa05231 | 0.15383225 |
| 138 | Phosphatidylinositol signaling system_Homo sapiens_hsa04070 | 0.13840292 |
| 139 | Regulation of lipolysis in adipocytes_Homo sapiens_hsa04923 | 0.13818932 |

